Clover Health exec covers taxes with 6,197 shares
Clover Health Investments executive Jamie L. Reynoso, CEO, Medicare Advantage, had 6,197 shares of Class A Common Stock withheld on April 3, 2026 to cover tax obligations.
Rhea-AI Filing Summary
Clover Health Investments executive Jamie L. Reynoso, CEO, Medicare Advantage, had 6,197 shares of Class A Common Stock withheld on April 3, 2026 to cover tax obligations. The withholding related to the vesting of 6.25% of restricted stock units granted on January 3, 2023.
After this tax-withholding disposition, Reynoso directly holds 2,869,922 shares of Class A Common Stock. The remaining RSUs from the 2023 grant will vest in equal quarterly installments through January 3, 2027, subject to Reynoso’s continued service on each vesting date.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Class A Common Stock | 6,197 | $1.72 | $11K |
Footnotes (1)
- F1. Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on April 3, 2026, of 6.25% of the restricted stock units ("RSUs") granted to the Reporting Person on January 3, 2023, and originally reported on a Form 4 filed on January 5, 2023. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on January 3, 2027, in each case subject to the continued service of the Reporting Person on each such vesting date.
Key Figures
Key Terms
restricted stock units ("RSUs") financial
vesting financial
tax obligations financial
Class A Common Stock financial
equal quarterly installments financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Clover Health (CLOV) executive Jamie Reynoso report in this Form 4?
What is the vesting schedule of Jamie Reynoso’s Clover Health RSUs from 2023?
AI-generated analysis. How Rhea-AI works. Not financial advice.